SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+2.86%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.97B
AUM Growth
-$23M
(-0.77%)
Cap. Flow
-$59M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
27.52%
Holding
462
New
54
Increased
149
Reduced
151
Closed
64
Top Buys
| 1 |
General Dynamics
GD
|
$52.2M |
| 2 |
AbbVie
ABBV
|
$37.3M |
| 3 |
Darden Restaurants
DRI
|
$35.5M |
| 4 |
MSCI
MSCI
|
$33.9M |
| 5 |
JNPR
Juniper Networks
JNPR
|
$33.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$46.5M |
| 2 |
Union Pacific
UNP
|
$39.8M |
| 3 |
VeriSign
VRSN
|
$37.8M |
| 4 |
Jack Henry & Associates
JKHY
|
$36.2M |
| 5 |
Booz Allen Hamilton
BAH
|
$33.9M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 18.74% |
| 3 | Consumer Discretionary | 14.61% |
| 4 | Industrials | 11.13% |
| 5 | Financials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
HNI Corp
HNI
$2.12B
| $1.82M | 0.06% |
35,726
+29,000
| +431% | +$1.48M |
|
152
Hackett Group
HCKT
$568M
| $1.75M | 0.06% |
129,940
-1,270
| -1% | -$17.1K |
|
153
Xencor
XNCR
$613M
| $1.72M | 0.06% |
78,400
+1,300
| +2% | +$28.6K |
|
|
ADMS
154
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.72M | 0.06% |
65,650
+1,200
| +2% | +$31.5K |
|
|
PES
155
DELISTED
Pioneer Energy Services Corp.
PES
| $1.61M | 0.05% |
253,860
+4,670
| +2% | +$29.6K |
|
156
Denny's
DENN
$232M
| $1.58M | 0.05% |
+136,120
| New | +$1.58M |
|
157
Opko Health
OPK
$1.07B
| $1.57M | 0.05% |
97,570
+1,690
| +2% | +$27.2K |
|
|
AGEN
158
Agenus
AGEN
$135M
| $1.48M | 0.05% |
+8,753
| New | +$1.48M |
|
|
GNCA
159
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.43M | 0.05% |
+13,004
| New | +$1.43M |
|
|
AXAS
160
DELISTED
Abraxas Petroleum Corporation
AXAS
| $1.42M | 0.05% |
24,043
+18,896
| +367% | +$1.12M |
|
|
TVRD
161
Tvardi Therapeutics, Inc. Common Stock
TVRD
$290M
| $1.39M | 0.05% |
+3,171
| New | +$1.39M |
|
|
TESO
162
DELISTED
Tesco Corp
TESO
| $1.35M | 0.05% |
123,370
+2,290
| +2% | +$25K |
|
|
IMGN
163
DELISTED
Immunogen Inc
IMGN
| $1.34M | 0.05% |
92,950
+1,790
| +2% | +$25.7K |
|
164
Inovio Pharmaceuticals
INO
$142M
| $1.22M | 0.04% |
12,497
+250
| +2% | +$24.5K |
|
165
Surmodics
SRDX
$474M
| $1.22M | 0.04% |
52,000
+800
| +2% | +$18.7K |
|
|
FLXN
166
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.15M | 0.04% |
52,500
+1,100
| +2% | +$24.1K |
|
|
CDMO
167
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.14M | 0.04% |
+124,393
| New | +$1.14M |
|
168
Xoma
XOMA
$427M
| $1.12M | 0.04% |
14,437
+279
| +2% | +$21.6K |
|
|
FPRX
169
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $990K | 0.03% |
39,850
+600
| +2% | +$14.9K |
|
|
NTUS
170
DELISTED
Natus Medical Inc
NTUS
| $940K | 0.03% |
22,080
+390
| +2% | +$16.6K |
|
171
Usana Health Sciences
USNA
$573M
| $932K | 0.03% |
13,640
+380
| +3% | +$26K |
|
|
RPXC
172
DELISTED
RPX Corporation
RPXC
| $930K | 0.03% |
55,010
+1,100
| +2% | +$18.6K |
|
|
SCAI
173
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $909K | 0.03% |
23,690
+400
| +2% | +$15.3K |
|
174
Ironwood Pharmaceuticals
IRWD
$187M
| $899K | 0.03% |
88,994
-8,823
| -9% | -$89.1K |
|
175
BGC Group
BGC
$4.68B
| $884K | 0.03% |
157,024
+3,095
| +2% | +$17.4K |
|